Loading...
Header Logo
Keywords
Last Name
Institution

Dr Farrokh Modabber

Title[no position]
Institution[no institution name]
Address[no address]
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mears ER, Modabber F, Don R, Johnson GE. A Review: The Current In Vivo Models for the Discovery and Utility of New Anti-leishmanial Drugs Targeting Cutaneous Leishmaniasis. PLoS Negl Trop Dis. 2015; 9(9):e0003889. PMID: 26334763; PMCID: PMC4559374.
    2. Sharifi I, Aflatoonian MR, Fekri AR, Hakimi Parizi M, Aghaei Afshar A, Khosravi A, Sharifi F, Aflatoonian B, Khamesipour A, Dowlati Y, Modabber F, Nadim A. A comprehensive review of cutaneous leishmaniasis in kerman province, southeastern iran-narrative review article. Iran J Public Health. 2015 Mar; 44(3):299-307. PMID: 25905072; PMCID: PMC4402407.
    3. Das S, Freier A, Boussoffara T, Das S, Oswald D, Losch FO, Selka M, Sacerdoti-Sierra N, Schönian G, Wiesmüller KH, Seifert K, Schroff M, Juhls C, Jaffe CL, Roy S, Das P, Louzir H, Croft SL, Modabber F, Walden P. Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci Transl Med. 2014 Apr 30; 6(234):234ra56. PMID: 24786324.
      View in: PubMed
    4. Olliaro P, Vaillant M, Arana B, Grogl M, Modabber F, Magill A, Lapujade O, Buffet P, Alvar J. Methodology of clinical trials aimed at assessing interventions for cutaneous leishmaniasis. PLoS Negl Trop Dis. 2013; 7(3):e2130. PMID: 23556016; PMCID: PMC3605149.
    5. Alimohammadian MH, Jones SL, Darabi H, Riazirad F, Ajdary S, Shabani A, Rezaee MA, Mohebali M, Hosseini Z, Modabber F. Assessment of interferon-? levels and leishmanin skin test results in persons recovered for leishmaniasis. Am J Trop Med Hyg. 2012 Jul; 87(1):70-5. PMID: 22764294; PMCID: PMC3391060.
    6. Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P, Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011 Feb 05; 377(9764):477-86. PMID: 21255828.
      View in: PubMed
    7. Dujardin JC, Herrera S, do Rosario V, Arevalo J, Boelaert M, Carrasco HJ, Correa-Oliveira R, Garcia L, Gotuzzo E, Gyorkos TW, Kalergis AM, Kouri G, Larraga V, Lutumba P, Macias Garcia MA, Manrique-Saide PC, Modabber F, Nieto A, Pluschke G, Robello C, Rojas de Arias A, Rumbo M, Santos Preciado JI, Sundar S, Torres J, Torrico F, Van der Stuyft P, Victoir K, Olesen OF. Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis. 2010 Oct 26; 4(10):e780. PMID: 21049009; PMCID: PMC2964298.
    8. Modabber F. Leishmaniasis vaccines: past, present and future. Int J Antimicrob Agents. 2010 Nov; 36 Suppl 1:S58-61. PMID: 20801000.
      View in: PubMed
    9. Sharifi I, Fekri AR, Aflatoonian MR, Khamesipour A, Mahboudi F, Dowlati Y, Nadim A, Modabber F. Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006. Int J Dermatol. 2010 May; 49(5):557-61. PMID: 20534092.
      View in: PubMed
    10. Musa AM, Noazin S, Khalil EA, Modabber F. Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration. Trans R Soc Trop Med Hyg. 2010 Jan; 104(1):1-2. PMID: 19712953.
      View in: PubMed
    11. Noazin S, Khamesipour A, Moulton LH, Tanner M, Nasseri K, Modabber F, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Smith PG. Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis. Vaccine. 2009 Jul 30; 27(35):4747-53. PMID: 19540273.
      View in: PubMed
    12. Noazin S, Modabber F, Khamesipour A, Smith PG, Moulton LH, Nasseri K, Sharifi I, Khalil EA, Bernal ID, Antunes CM, Kieny MP, Tanner M. First generation leishmaniasis vaccines: a review of field efficacy trials. Vaccine. 2008 Dec 09; 26(52):6759-67. PMID: 18950671.
      View in: PubMed
    13. Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg. 2008 Jan; 102(1):58-63. PMID: 17963805.
      View in: PubMed
    14. Ghalib H, Modabber F. Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis. Kinetoplastid Biol Dis. 2007 Aug 17; 6:7. PMID: 17705861; PMCID: PMC2000869.
    15. Modabber F, Buffet PA, Torreele E, Milon G, Croft SL. Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006. Kinetoplastid Biol Dis. 2007 Apr 24; 6:3. PMID: 17456237; PMCID: PMC1868746.
    16. Badaro R, Lobo I, Munos A, Netto EM, Modabber F, Campos-Neto A, Coler RN, Reed SG. Immunotherapy for drug-refractory mucosal leishmaniasis. J Infect Dis. 2006 Oct 15; 194(8):1151-9. PMID: 16991091.
      View in: PubMed
    17. Nylén S, Khamesipour A, Mohammadi A, Jafari-Shakib R, Eidsmo L, Noazin S, Modabber F, Akuffo H. Surrogate markers of immunity to Leishmania major in leishmanin skin test negative individuals from an endemic area re-visited. Vaccine. 2006 Nov 17; 24(47-48):6944-54. PMID: 17049693.
      View in: PubMed
    18. Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F. Leishmaniasis vaccine candidates for development: a global overview. Indian J Med Res. 2006 Mar; 123(3):423-38. PMID: 16778321.
      View in: PubMed
    19. Vélez ID, Gilchrist K, Arbelaez MP, Rojas CA, Puerta JA, Antunes CM, Zicker F, Modabber F. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia. Trans R Soc Trop Med Hyg. 2005 Aug; 99(8):593-8. PMID: 15893351.
      View in: PubMed
    20. Khamesipour A, Dowlati Y, Asilian A, Hashemi-Fesharki R, Javadi A, Noazin S, Modabber F. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine. 2005 May 25; 23(28):3642-8. PMID: 15882524.
      View in: PubMed
    21. Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Dichotomy of protective cellular immune responses to human visceral leishmaniasis. Clin Exp Immunol. 2005 May; 140(2):349-53. PMID: 15807861; PMCID: PMC1809358.
    22. Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG. Clin Exp Immunol. 2003 Nov; 134(2):303-8. PMID: 14616791; PMCID: PMC1808866.
    23. Asilian A, Jalayer T, Nilforooshzadeh M, Ghassemi RL, Peto R, Wayling S, Olliaro P, Modabber F. Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull World Health Organ. 2003; 81(5):353-9. PMID: 12856053; PMCID: PMC2572463.
    24. Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis. Vaccine. 2002 Dec 13; 21(3-4):174-80. PMID: 12450691.
      View in: PubMed
    25. Coler RN, Skeiky YA, Bernards K, Greeson K, Carter D, Cornellison CD, Modabber F, Campos-Neto A, Reed SG. Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis. Infect Immun. 2002 Aug; 70(8):4215-25. PMID: 12117930; PMCID: PMC128156.
    26. Machado-Pinto J, Pinto J, da Costa CA, Genaro O, Marques MJ, Modabber F, Mayrink W. Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial. Int J Dermatol. 2002 Feb; 41(2):73-8. PMID: 11982640.
      View in: PubMed
    27. Gicheru MM, Olobo JO, Anjili CO, Orago AS, Modabber F, Scott P. Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect Immun. 2001 Jan; 69(1):245-51. PMID: 11119512; PMCID: PMC97878.
    28. Vélez ID, del Pilar Agudelo S, Arbelaez MP, Gilchrist K, Robledo SM, Puerta JA, Zicker F, Berman J, Modabber F. Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial. Trans R Soc Trop Med Hyg. 2000 Nov-Dec; 94(6):698-703. PMID: 11198661.
      View in: PubMed
    29. Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran. Lancet. 1998 May 23; 351(9115):1540-3. PMID: 10326536.
      View in: PubMed
    30. Engers HD, Bergquist R, Modabber F. Progress on vaccines against parasites. Dev Biol Stand. 1996; 87:73-84. PMID: 8854004.
      View in: PubMed
    31. Mirkovich AM, Galelli A, Allison AC, Modabber FZ. Increased myelopoiesis during Leishmania major infection in mice: generation of 'safe targets', a possible way to evade the effector immune mechanism. Clin Exp Immunol. 1986 Apr; 64(1):1-7. PMID: 3488146; PMCID: PMC1542165.
    32. Bahr GM, Modabber FZ, Morin A, Terrier M, Eyquem A, Chedid L. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells. Clin Exp Immunol. 1984 Jul; 57(1):178-86. PMID: 6744667; PMCID: PMC1536095.
    33. Phillips NC, Bahr GM, Modabber FZ, Chedid L. Modulation of the growth of murine thymoma cell lines having different Lyt-phenotypes by MDP and MDP(D-D): macrophage-mediated inhibition of in vitro cell growth. Int J Immunopharmacol. 1984; 6(6):577-85. PMID: 6334660.
      View in: PubMed
    34. Bahr GM, Modabber FZ, Rook GA, Mehrotra ML, Stanford JL, Chedid L. Absence of antibodies to muramyl dipeptide in patients with tuberculosis or leprosy. Clin Exp Immunol. 1982 Jan; 47(1):53-8. PMID: 6807589; PMCID: PMC1536355.
    35. Nasseri M, Modabber FZ. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major. Infect Immun. 1979 Nov; 26(2):611-4. PMID: 546790; PMCID: PMC414661.
    36. Hashemi S, Dowlatshahi K, Day NE, Kmet J, Takasugi M, Mohaghpour N, Modabber FZ. Esophageal cancer studies in the Caspian Littoral of Iran: introductive assessment of the HLA profile in patients and controls. Tissue Antigens. 1979 Nov; 14(5):422-5. PMID: 12731573.
      View in: PubMed
    37. Modabber FZ, Bahr GM. Binding of antigen-enzyme complex by antigen-binding cells as an approach for immunogdiagnosis. Infect Immun. 1979 Jan; 23(1):49-53. PMID: 106005; PMCID: PMC550688.
    38. Hafizi A, Modabber FZ. Effect of cyclophosphamide on Toxoplasma gondii infection: reversal of the effect by passive immunization. Clin Exp Immunol. 1978 Sep; 33(3):389-94. PMID: 737894; PMCID: PMC1537435.
    Modabber's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description